Re-evaluation of quality control guidelines for gatifloxacin and garenoxacin (BMS284756) when susceptibility testing Haemophilus influenzaeStreptococcus pneumoniae.
Re-evaluation of quality control guidelines for gatifloxacin and garenoxacin (BMS284756) when susceptibility testing Haemophilus influenzae and Streptococcus pneumoniae. by Anderegg TR, Biedenbach DJ, Jones RN and The Quality Control Working Group published in Diagn. Microbiol. Infect. Dis. 1996; 46: 147-150
